Development of carbapenem resistance during therapy for non-typhoid Salmonella infection

Clinical Microbiology and Infection

Volumn 18, Issue 4, 2012, Pages

  Su, L H ^a,b   Wu, T L ^a,b   Chiu, C H ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Carbapenem resistance; IncI1 plasmid; Non typhoid Salmonella; Porin loss; Tn6092

Indexed keywords

CARBAPENEM; ERTAPENEM; IMIPENEM;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIUM ISOLATE; CASE REPORT; CHRONIC KIDNEY FAILURE; DEBRIDEMENT; DIARRHEA; FECES CULTURE; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; NEPHRITIS; NOTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; URINARY TRACT INFECTION; URINE CULTURE;

SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 84858703804     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2012.03767.x     Document Type: Article

References (20)

1. Vugia DJ, Samuel M, Farley MM et al. Invasive Salmonella infections in the United States, Food-Net, 1996-1999: incidence, serotype distribution, and outcome. Clin Infect Dis 2004; 38 (suppl 3): S149-S156.
2. Su LH, Chiu CH, Chu C, Ou JT. Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. Clin Infect Dis 2004; 39: 546-551.
3. Jean SS, Lee YT, Guo SM, Hsueh PR. Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis treated successfully with imipenem. J Infect 2005; 51: e163-e165.
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 20th Informational Supplement; CLSI document M100-S20. Wayne, PA: CLSI, 2010.
5. Su LH, Leu HS, Chiu YP et al. Molecular investigation of two clusters of nosocomial bacteraemia caused by multiresistant Klebsiella pneumoniae using pulsed-field gel electrophoresis and infrequent-restriction-site PCR. J Hosp Infect 2000; 46: 110-117.
6. CMY-2 among Salmonella and other Enterobacteriaceae. J Antimicrob Chemother 2006; 57: 424-429.
7. Chia JH, Siu LK, Su LH et al. Emergence of carbapenem-resistant Escherichia coli in Taiwan: resistance due to the combination of CMY-2 production and porin deficiencies. J Chemother 2009; 21: 621-626.
8. Chia JH, Su LH, Lee MH et al. Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure. Microb Drug Resist 2010; 16: 317-325.
9. García-Fernández A, Chiaretto G, Bertini A et al. Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum β-lactamases in Escherichia coli and Salmonella of human and animal origin. J Antimicrob Chemother 2008; 61: 1229-1233.
10. Su LH, Teng WS, Chen CL et al. Increasing ceftriaxone resistance in salmonellae, Taiwan. Emerg Infect Dis 2011; 17: 1086-1090.
11. Chiu CH, Su LH, Chu C et al. Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin. Lancet 2004; 363: 1285-1286.
12. Armand-Lefèvre L, Leflon-Guibout V, Bredin J et al. Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 β-lactamase production. Antimicrob Agents Chemother 2003; 47: 1165-1168.
13. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-β-lactamases: a last frontier for β-lactams? Lancet Infect Dis 2011; 11: 381-393.
14. Miriagou V, Tzouvelekis LS, Rossiter S, Tzelepi E, Angulo FJ, Whichard JM. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother 2003; 47: 1297-1300.
15. O'Mahony R, Quinn T, Drudy D et al. Antimicrobial resistance in nontyphoidal Salmonella from food sources in Colombia: evidence for an unusual plasmid-localized class 1 integron in serotypes Typhimurium and Anatum. Microb Drug Resist 2006; 12: 269-277.
16. Nordmann P, Poirel L, Mak JK, White PA, McIver CJ, Taylor P. Multidrug-resistant Salmonella strains expressing emerging antibiotic resistance determinants. Clin Infect Dis 2008; 46: 324-325.
17. Lee HY, Su LH, Tsai MH et al. High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia. Antimicrob Agents Chemother 2009; 53: 2696-2699.
18. Jabeen K, Zafar A, Irfan S, Khan E, Mehraj V, Hasan R. Increase in isolation of extended spectrum beta lactamase producing multidrug resistant non typhoidal Salmonellae in Pakistan. BMC Infect Dis 2010; 10: 101.
19. Gupta A, Fontana J, Crowe C et al. Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States. J Infect Dis 2003; 188: 1707-1716.
20. Chen CL, Su LH, Chiu CH. Transcription modulation of gene expression in Salmonella enterica serotype Choleraesuis by sub-inhibitory concentrations of ciprofloxacin. Food Res Int 2012; 45: 971-975.